Allergan Breast Implants

A leading name in the breast implant manufacturing industry, Allergan ventured into the breast implants category in 2006 and is now considered the largest company in its category in the world with presence in more than 60 countries. The company’s primary markets are the US, Latin America, and Canada as these regions contribute significantly to the overall revenue of the company. Natrelle® is the flagship brand of Allergan but it also sells products through its subsidiaries McGhan and Inamed.

Among the medical fraternity, Allergan is the most preferred name for various products, but recently health regulators have identified a correlation between the company’s Biocell textured breast implants and Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). BIA-ALCL is a rare but treatable kind of Non-Hodgkin Lymphoma (NHL).

FAQs

Textured implants are also referred to as gummy bear breast implants that are identical to sandpaper and have outer shell which are textured. The cause of why the texturing leads to the development of cancer in a few patients is not known, but it does lead to that.  

On July 24, 2019 Allergan initiated a campaign to establish contact with all the patients who used its Biocell textured breast implants and tissue expanders after FDA established a correlation that it is causing BIA-ALCL among the patients. But a class action lawsuit against Allergan was filed on August 16, 2019 in the U.S. District Court for the District of New Jersey.

If you or someone you care about have Allergan’s harmful products in your body and the following signs & symptoms are appearing, then you should first of all get it checked:

Capsular contracture

Collection of fluid around the breast implant area

Lump under the skin

Pain, presence of mass, or swelling around the breast implant area

In case any unfortunate diagnosis, then come forward to seek financial compensation for your sufferings.

Since BIA-ALCL is rare and a global surge is noticed in the number of cases, the FDA analyzed the situation and detected that out of the total 573 cases around 481 patients have received Allergan Biocell Textured Breast Implant, which was the reason attributed for product recall by Allergan. After people realized that their condition is due to a product they have used, they filed a class action lawsuit to seek justice for themselves or for their loved ones. If you are suffering from it too, then join the others because it is your right.